Quote LOL, "Got a response from Blue Cross :) They affirmed it. :D "
Yep, they "Affirmed" it all right:
Blue Cross, Blue Shield DO NOT COVER ANYTHING, ANY PRODUCT or ANY SERVICE that USRM sells.
Myocell per Blue Cross/Shield is considered "investigative" and thus has no known or proven scientific efficacy and is NOT CONSIDERED A VALID SCIENTIFIC, "STANDARD OF CARE" and "NOT MEDICALLY NECESSARY" and thus Blue Cross/Shield WILL NOT, and DOES NOT cover any procedure or costs related to such "stem cell therapy for cardiac conditions", let alone ANYTHING related to "Myocell" or anything USRM offers, which they have NO FDA APPROVED PRODUCTS, other than a catheter, which comes off patent in Sept of this year.
Yep, CONFIRMED. 100%. NO PAYMENT FROM ANY insurance carried in this nation. USRM SEC filings state thee exact same FACTS.
FROM THEE Blue Cross Insurance web site:
"MyoCell® (Bioheart, Sunrise, FL) comprises patient autologous skeletal myoblasts that are expanded ex vivo and supplied as a cell suspension in a buffered salt solution for injection into the area of damaged myocardium. MyoCell® SDF-1 (Bioheart) is similar to MyoCell®, but before injection, myoblast cells are genetically modified to release excess stromal-derived factor-1 (SDF-1). Increased SDF-1 levels at the site of myocardial damage may accelerate recruitment of native stem cells to increase tissue repair and neovascularization. For both products, myoblast isolation and expansion occur at a single reference laboratory (Bioheart); both products are therefore subject to FDA approval. Currently, neither product has been cleared by the FDA. Implantation may require use of a unique catheter delivery system (eg, MyoCath [Bioheart]) that has been cleared by the FDA."
AND
"Investigative is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized as a generally accepted standard of good medical practice for the treatment of the condition being treated and; therefore, is not considered medically necessary. For the definition of Investigative, [color=blue]“generally accepted standards of medical practice” means standards that are based on credible scientific evidence published in peer-reviewed medical literature generally recognized by the relevant medical community, and physician specialty society recommendations, and the views of medical practitioners practicing in relevant clinical areas and any other relevant factors. In order for equipment, devices, drugs or supplies [i.e, technologies], to be considered not investigative, the technology must have final approval from the appropriate governmental bodies, and scientific evidence must permit conclusions concerning the effect of the technology on health outcomes, and the technology must improve the net health outcome, and the technology must be as beneficial as any established alternative and the improvement must be attainable outside the testing/investigational setting.[/color]"
MYOCELL, it meets NONE of the Blue Cross/Shield criteria as a "valid, scientifically proven "treatment" and one of "medical necessity" and one with appropriate "governmental APPROVALS" and thus, THEY WILL NOT, and DO NOT PAY FOR IT, NOR REIMBURSE COSTS FOR IT. End of sad story.
Great DIS-INFORMATION attempts here though. FANTASTIC.
Posts are only my amateur opinions, personal views and thoughts. They are not any type of investment advice. Do one's own due diligence.
